| pubmed-article:7795323 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C0034715 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C0205065 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C0597513 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C0486805 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C1516048 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C1515926 | lld:lifeskim |
| pubmed-article:7795323 | lifeskim:mentions | umls-concept:C0599787 | lld:lifeskim |
| pubmed-article:7795323 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7795323 | pubmed:dateCreated | 1995-8-3 | lld:pubmed |
| pubmed-article:7795323 | pubmed:abstractText | This study was conducted to determine the utility of using steroid production by cultured ovarian fragments to assess toxicant-induced alterations in ovarian steroidogenesis in Sprague-Dawley rats. To this end, serum steroid concentration and steroid production (progesterone (P4), testosterone (T), estradiol (E2)) by cultured ovarian fragments is described during a normal 4-day estrous cycle. This culture system was then used to profile the effects of aminoglutethimide shown to have two sites of steroidogenic inhibition, side chain cleavage enzyme and aromatase. LH, FSH, P4, and E2 concentrations in serum during the 4-day estrous cycle confirmed that described in the literature for untreated rats. All of the steroids measured had peak production levels during proestrus. The patterns of P4 and E2 production by the ovaries in an unstimulated culture mimics that seen in serum. Stimulation with hCG (100 mIU/mL) after the initial 1 h culture tends to even out the production of P4, while T production rises faster and peaks earlier. The pattern and levels of estradiol production in hCG-stimulated cultures are very similar to those in the unstimulated culture, both in pattern and in production levels. When cultured ovarian fragments from proestrous rats were treated in vitro with aminoglutethimide (1 to 16 microM), the pattern of steroid production that characterized the inhibitory effects were similar to those reported in the literature using isolated cell culture procedures. This pattern showed a rapid decrease in E2 production (IC50 of 2.43 microM), a concurrent rise in T production, and a decrease in P4 production (IC50 of 15.5 microM). This culture system is an appropriate system to rapidly assess toxicant effects on ovarian steroidogenesis following in vivo or in vitro exposure. | lld:pubmed |
| pubmed-article:7795323 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7795323 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7795323 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7795323 | pubmed:issn | 0890-6238 | lld:pubmed |
| pubmed-article:7795323 | pubmed:author | pubmed-author:BermanEE | lld:pubmed |
| pubmed-article:7795323 | pubmed:author | pubmed-author:LaskeyJ WJW | lld:pubmed |
| pubmed-article:7795323 | pubmed:author | pubmed-author:FerrellJ MJM | lld:pubmed |
| pubmed-article:7795323 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7795323 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:7795323 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7795323 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7795323 | pubmed:pagination | 131-41 | lld:pubmed |
| pubmed-article:7795323 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:meshHeading | pubmed-meshheading:7795323-... | lld:pubmed |
| pubmed-article:7795323 | pubmed:articleTitle | The use of cultured ovarian fragments to assess toxicant alterations in steroidogenesis in the Sprague-Dawley rat. | lld:pubmed |
| pubmed-article:7795323 | pubmed:affiliation | Development Toxicology Division, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. | lld:pubmed |
| pubmed-article:7795323 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7795323 | lld:pubmed |
